A HYBRID CONFERENCE AND INTERNET EVENT

25th Annual Pharmaceutical
and Medical Device Ethics
and Compliance Congress

October 28-30, 2024

Hybrid Onsite Conference & Internet Event — Live and Archived
Grand Hyatt Washington
Washington, DC

Follow Pharma Congress on:  


David Ralston, JD

Managed Care Attorney Consultant; Market Access Legal Specialist, Biogen and Rocket Pharmaceuticals, Boston, MA

Nikki Reeves, JD

Partner & Co-chair, Life Sciences & Healthcare Industry Group, King & Spalding, Washington, DC

Timothy Roberts, MA

Global Chief Compliance Officer, Legend Biotech; Former US Compliance & Privacy Officer, Ferring, Mendham, NJ

Tad Roselund

Managing Director & Senior Partner and Former Chief Risk Officer, The Boston Consulting Group, Montclair, NJ

Elan Schefflein, JD

Senior Compliance Advisor, MedPro Systems, New York, NY

Sulin Shah, JD

Law Offices of Sulin Shah; Legal Consultant, Soleno Therapeutics; Former VP, US General Counsel, PharmaEssentia & Orphazyme A/S, Chicago, IL

Alexis Shaw

Deputy Chief Compliance Officer, Paratek; Former Compliance Officer, Endo, Malvern, PA

Michael L. Shaw, JD

Global Head of Compliance, Privacy & Risk, ZS; Former VP & Compliance Officer, GlaxoSmithKline; Former Senior Counsel, HHS OIG, Princeton, NJ

Paul Silver

Corporate Intelligence Services Practice Leader, Life Sciences Regulatory, Legal, & Compliance Leader, Deloitte Advisory, Atlanta, GA

Sara R. Simon, JD

Counsel, Porzio, Bromberg & Newman; Former Director, US Health Care Compliance Certification Program, Seton Hall University School of Law, Morristown, NJ

Laura A. Skinner, MBA

Managing Director, Life Sciences Consulting Group, Paul Hastings, New York, NY

Mike Stanek, JD

Associate Vice President, Assistant General Counsel, Eli Lilly and Company, Indianapolis, IN

Kelly J. Tope, JD, MBA

Head of USBU Ethics & Compliance Monitoring & Reporting Operations, Takeda; Former Global Director, Compliance, Transparency, Monitoring, Biomet, Boston, MA

Natasha Trifun, JD

Executive Director, Head of Compliance, R&D, Global Medical, External Funding & Global Functions, Alexion, AstraZeneca Rare Disease, Boston, MA

L. Stephan Vincze, JD, LLM, MBA

President & CEO, TRESTLE Compliance; Former SVP and CCO, Warner Chilcot; Former VP, Ethics and Compliance Officer, TAP Pharmaceutical, Boston, MA

Tyler Wiseman, MBA, JD

Chief Legal Officer, Elevar Therapeutics; Former Corporate Counsel, Praxis Precision Medicines, Boston, MA

Ronald L. Wisor, Jr, JD

Partner, Lifesciences & Healthcare, Hogan Lovells, Washington, DC



FEATURING THE PHARMA & MEDICAL DEVICE CONGRESS ADVANCED VIRTUAL INTERACTIVE VIDEO BROADCAST PORTAL

Featuring one-on-one attendee video chat and large group video interactive workshops.
See last year’s Congress portal: